The University of Chicago
Chicago, Illinois, 60637, United States
Location status: Recruiting
NCT Number: NCT00515567
The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Chicago, Illinois, 60637, United States
Location status: Recruiting
Pulmonary Fibrosis involves scarring of the lung. Gradually, the air sacs of the lungs become replaced by fibrotic tissue. The most current thinking is that the fibrotic process is a reaction to tiny injury to the lung. When the scar forms, the tissue becomes thicker causing a permanent loss of the tissue's ability to carry oxygen into the bloodstream.
We need to obtain lung tissue from patients without pulmonary fibrosis and compare it to lung tissue from patients with pulmonary fibrosis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12/2013
Contact information is provided by the study sponsor or research team.
University of Chicago
Other
Utilization of Explanted Lungs for Isolation of Tissue Samples and Primary Cell Lines to Study Pulmonary Fibrosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001532
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07572383
Fibrosis, Interstitial Lung Disease
Boston, Massachusetts, United States
View Trial DetailsNCT05392881
Alveolitis, Extrinsic Allergic, Fibrosis
Kansas City, Kansas, United States
View Trial DetailsNCT06162884
Fibrosis, Lung Diseases
Los Angeles, California, United States
View Trial Details